| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Steno Diabetes Center and Hagedorn Research Institute (S.K.R., L.H., S.M.E., T.H., C.T.E., S.A.U., K.B.-J., O.P.), DK-2820, Gentofte, Denmark; Institut Universitaire de Recherche Clinique, Molecular Endocrinology Laboratory (C.L., F.G.), 34093 Montpellier, France; Joslin Diabetes Center, Harvard Medical School (R.J.S.), Boston, Massachusetts 02215; and Center of Preventive Medicine, Glostrup University Hospital (K.B.-J.), DK-2820 Glostrup, Denmark
Address all correspondence and requests for reprints to: Søren K. Rasmussen, M.Sc., Steno Diabetes Center and Hagedorn Research Institute, Niels Steensens Vej 2-6, DK-2820, Gentofte, Denmark.
Insulin-like growth factor I (IGF-I) is an important regulator of many aspects of growth, differentiation, and development, and as low birth weight has been associated with impaired glucose tolerance and overt type 2 diabetes in adult life, we considered the genes encoding the IGF-I and the IGF-I receptor (IGF-IR) as candidates for low birth weight, insulin resistance, and type 2 diabetes. Here we report the mutational analysis of the coding regions of the IGF-I and IGF-IR performed on genomic DNA from probands of 82 Danish type 2 diabetic families. No mutations predicting changes in the amino acid sequences of the IGF-I or IGF-IR genes were detected, but several silent and intronic polymorphisms were found. The impact of the most prevalent polymorphism, GAG1013GAA of the IGF-IR, was evaluated in a population-based sample of 349 young healthy subjects, where the variant had an allele frequency of 0.44 (95% confidence interval, 0.400.48). No significant relationships between this variant and birth weight, birth length, or insulin sensitivity index were detected. In addition, we did not observe any significant differences in allelic frequencies of the codon 1013 variant between 395 type 2 diabetic patients (allele frequency, 0.52; 95% confidence interval, 0.490.55) and 238 matched glucose-tolerant control subjects (allelic frequency, 0.47; 95% confidence interval, 0.430.50). In conclusion, variability in the coding regions of IGF-I and the IGF-IR does not associate with reduced birth weight, insulin sensitivity index, or type 2 diabetes in the Danish population.
This article has been cited by other articles:
![]() |
G. Holmstrom, P. van Wijngaarden, D. J Coster, and K. A Williams Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies Br. J. Ophthalmol., December 1, 2007; 91(12): 1704 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Estany, M. Tor, D. Villalba, L. Bosch, D. Gallardo, N. Jimenez, L. Altet, J. L. Noguera, J. Reixach, M. Amills, et al. Association of CA repeat polymorphism at intron 1 of insulin-like growth factor (IGF-I) gene with circulating IGF-I concentration, growth, and fatness in swine Physiol Genomics, October 19, 2007; 31(2): 236 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawashima, S. Kanzaki, F. Yang, T. Kinoshita, K. Hanaki, J.-i. Nagaishi, Y. Ohtsuka, I. Hisatome, H. Ninomoya, E. Nanba, et al. Mutation at Cleavage Site of Insulin-Like Growth Factor Receptor in a Short-Stature Child Born with Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4679 - 4687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kostek, M. J. Delmonico, J. B. Reichel, S. M. Roth, L. Douglass, R. E. Ferrell, and B. F. Hurley Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults J Appl Physiol, June 1, 2005; 98(6): 2147 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1394 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter Insulin-like Growth Factor Polymorphisms and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1204 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fletcher, L. Gibson, N. Johnson, D. R. Altmann, J. M.P. Holly, A. Ashworth, J. Peto, and I. d. S. Silva Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 2 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. San Millan, M. Corton, G. Villuendas, J. Sancho, B. Peral, and H. F. Escobar-Morreale Association of the Polycystic Ovary Syndrome with Genomic Variants Related to Insulin Resistance, Type 2 Diabetes Mellitus, and Obesity J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2640 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rivadeneira, J. J. Houwing-Duistermaat, N. Vaessen, J. M. Vergeer-Drop, A. Hofman, H. A. P. Pols, C. M. van Duijn, and A. G. Uitterlinden Association between an Insulin-Like Growth Factor I Gene Promoter Polymorphism and Bone Mineral Density in the Elderly: The Rotterdam Study J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3878 - 3884. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Frayling, A. T. Hattersley, A. McCarthy, J. Holly, S. M.S. Mitchell, A. L. Gloyn, K. Owen, D. Davies, G. D. Smith, and Y. Ben-Shlomo A Putative Functional Polymorphism in the IGF-I Gene: Association Studies With Type 2 Diabetes, Adult Height, Glucose Tolerance, and Fetal Growth in U.K. Populations Diabetes, July 1, 2002; 51(7): 2313 - 2316. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |